272 related articles for article (PubMed ID: 35880350)
41. Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Xia W; Liu Y
Medicine (Baltimore); 2019 Jul; 98(27):e16296. PubMed ID: 31277164
[TBL] [Abstract][Full Text] [Related]
42. Multiple phosphaturic mesenchymal tumors associated with oncogenic osteomalacia: case report and review of the literature.
Peterson NR; Summerlin DJ; Cordes SR
Ear Nose Throat J; 2010 Jun; 89(6):E11-5. PubMed ID: 20556724
[TBL] [Abstract][Full Text] [Related]
43. Sphenoid sinus is a rare site for tumor-induced osteomalacia: A case report and literature review.
Wang F; He W; Ma D; Xu W; Xie J; Yuan G
Front Endocrinol (Lausanne); 2023; 14():1116793. PubMed ID: 37033241
[TBL] [Abstract][Full Text] [Related]
44. The phosphaturic mesenchymal tumor as a cause of oncogenic osteomalacia. Three cases and review of the literature.
Moreno Romero M; Pérez Muñoz I; González Lizán F; Gallego Rivera JI; Valdivielso Cañas L
Rev Esp Cir Ortop Traumatol (Engl Ed); 2021 Apr; ():. PubMed ID: 33903024
[TBL] [Abstract][Full Text] [Related]
45. Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.
Puthenveetil PJ; Hattab EM; Peacock M; Horn EM
J Clin Neurosci; 2013 Aug; 20(8):1057-61. PubMed ID: 23618679
[TBL] [Abstract][Full Text] [Related]
46. Tumor-Induced Osteomalacia.
Florenzano P; Hartley IR; Jimenez M; Roszko K; Gafni RI; Collins MT
Calcif Tissue Int; 2021 Jan; 108(1):128-142. PubMed ID: 32504138
[TBL] [Abstract][Full Text] [Related]
47. Phosphaturic mesenchymal tumors: what an endocrinologist should know.
Boland JM; Tebben PJ; Folpe AL
J Endocrinol Invest; 2018 Oct; 41(10):1173-1184. PubMed ID: 29446010
[TBL] [Abstract][Full Text] [Related]
48. A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue type.
Graham RP; Hodge JC; Folpe AL; Oliveira AM; Meyer KJ; Jenkins RB; Sim FH; Sukov WR
Hum Pathol; 2012 Aug; 43(8):1334-8. PubMed ID: 22503486
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
[TBL] [Abstract][Full Text] [Related]
50. Tumor-induced osteomalacia treated with T12 tumor resection.
Mancini AJ; Sabet A; Nielsen GP; Parker JA; Schwab JH; Ward A; Wu JS; Malabanan AO
Endocrinol Diabetes Metab Case Rep; 2022 Dec; 2022():. PubMed ID: 36511458
[TBL] [Abstract][Full Text] [Related]
51. Phosphaturic Mesenchymal Tumors in the Head and Neck Demonstrate a Broad Clinical and Morphologic Spectrum.
Hulme KR; Mahar A; Campbell RG; Clifton-Bligh R; Gill AJ; Palme CE; Gupta R
Head Neck Pathol; 2022 Sep; 16(3):902-912. PubMed ID: 35119617
[TBL] [Abstract][Full Text] [Related]
52. [Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].
Chazal T; Khanine V; Lidove O; Godot S; Ziza JM
Rev Med Interne; 2017 Jun; 38(6):412-415. PubMed ID: 27659744
[TBL] [Abstract][Full Text] [Related]
53. Pathologic quiz case. A 36-year-old woman with muscle pain and weakness. Phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia.
Reis-Filho JS; Paiva ME; Lopes JM
Arch Pathol Lab Med; 2002 Oct; 126(10):1245-6. PubMed ID: 12385334
[No Abstract] [Full Text] [Related]
54. Tumor-induced osteomalacia.
Chong WH; Molinolo AA; Chen CC; Collins MT
Endocr Relat Cancer; 2011 Jun; 18(3):R53-77. PubMed ID: 21490240
[TBL] [Abstract][Full Text] [Related]
55. Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
Medicine (Baltimore); 2020 Jan; 99(4):e18603. PubMed ID: 31977851
[TBL] [Abstract][Full Text] [Related]
56. [Clinical features, diagnostics and treatment of FGF23 secreting tumors: series of 40 clinical cases].
Gronskaia SA; Belaya ZE; Rozhinskaya LY; Melnichenko GA; Dubovitskaya TA; Mamedova EO; Rodionova SS; Buklemishev YV; Pigarova EA; Degtyarev MV; Babaeva DM; Vladimirova VP; Tarbaeva NV; Serzhenko SS; Grigoriev AY; Dzeranova LK; Karpenko VY; Karasev AL; Fedotov RN; Uliyanova IN; Toroptsova NV; Lesnyak OM; Mokrysheva NG; Dedov II
Probl Endokrinol (Mosk); 2023 Nov; 69(5):25-38. PubMed ID: 37968949
[TBL] [Abstract][Full Text] [Related]
57. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
[TBL] [Abstract][Full Text] [Related]
58. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
[TBL] [Abstract][Full Text] [Related]
59. Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report.
Qiu S; Cao LL; Qiu Y; Yan P; Li ZX; Du J; Sun LM; Zhang QF
Medicine (Baltimore); 2017 Apr; 96(17):e6750. PubMed ID: 28445300
[TBL] [Abstract][Full Text] [Related]
60. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
